8-K
Current Report
Keros Therapeutics, Inc. Filed Acc 0001104659-25-099512
Material agreement · Results of operations · Executive or director change · Regulation FD disclosure · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 2.02 Results of operations and financial condition
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading tm2528773d1_8k.htm…